Search Results

search

Search Filters

Organization
Lisata Therapeutics
LSTA Logo Final 6.8.22_Logo Color_Transparant Background (002).jpg
Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025
February 20, 2025 08:00 ET | Lisata Therapeutics, Inc. CLEAR® Verified
BASKING RIDGE, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies...
LSTA Logo Final 6.8.22_Logo Color_Transparant Background (002).jpg
Lisata Therapeutics to Present at the 2025 BIO CEO & Investor Conference
February 05, 2025 08:30 ET | Lisata Therapeutics, Inc. CLEAR® Verified
BASKING RIDGE, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies...
LSTA Logo Final 6.8.22_Logo Color_Transparant Background (002).jpg
Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma
January 23, 2025 08:00 ET | Lisata Therapeutics, Inc. CLEAR® Verified
Data corroborate previously reported preclinical data demonstrating certepetide’s ability to enhance the effectiveness of immunotherapy Preliminary results to be presented at the 2025 ASCO...
LSTA Logo Final 6.8.22_Logo Color_Transparant Background (002).jpg
Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma
January 22, 2025 08:00 ET | Lisata Therapeutics, Inc. CLEAR® Verified
Cohort A data to be presented in a poster session at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium Data reported positive trend in overall survival, including 4...
LSTA Logo Final 6.8.22_Logo Color_Transparant Background (002).jpg
Lisata Therapeutics to Present at the 2025 Sequire Investor Summit
January 15, 2025 08:30 ET | Lisata Therapeutics, Inc. CLEAR® Verified
BASKING RIDGE, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment...
LSTA Logo Final 6.8.22_Logo Color_Transparant Background (002).jpg
Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial
December 10, 2024 08:30 ET | Lisata Therapeutics, Inc.
BASKING RIDGE, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment...
LSTA Logo Final 6.8.22_Logo Color_Transparant Background (002).jpg
Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging
December 03, 2024 08:30 ET | Lisata Therapeutics, Inc.
BASKING RIDGE, N.J. and HOUSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage pharmaceutical company developing innovative therapies for...
Biotech Breakthrough Award 2024
Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’
November 19, 2024 08:30 ET | Lisata Therapeutics, Inc.
Award recognizes Lisata’s data-driven approach and innovative therapies designed to address the unmet medical needs of patients with advanced solid tumors Annual BioTech Breakthrough Award is devoted...
LSTA Logo Final 6.8.22_Logo Color_Transparant Background (002).jpg
Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024 16:05 ET | Lisata Therapeutics, Inc.
Robust and expanding development portfolio with multiple key data readouts projected over the next 18 months Conference call scheduled for today at 4:30 p.m. Eastern Time BASKING RIDGE, N.J., Nov. ...
LSTA Logo Final 6.8.22_Logo Color_Transparant Background (002).jpg
Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration
November 06, 2024 09:23 ET | Lisata Therapeutics, Inc.
BASKING RIDGE, N.J. and HELSINKI, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the...